Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Boehringer Ingelheim Vetmedica Gmbh patents (2018 archive)


Recent patent applications related to Boehringer Ingelheim Vetmedica Gmbh. Boehringer Ingelheim Vetmedica Gmbh is listed as an Agent/Assignee. Note: Boehringer Ingelheim Vetmedica Gmbh may have other listings under different names/spellings. We're not affiliated with Boehringer Ingelheim Vetmedica Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boehringer Ingelheim Vetmedica Gmbh-related inventors


Treatment of pigs with pcv2 antigen

The present invention relates to a method for the treatment or prophylaxis of a pcv2 infection or for reduction of clinical symptoms caused by or associated with a pcv2 infection in animals a) having anti-pcv2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a pcv2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.. ... Boehringer Ingelheim Vetmedica Gmbh

Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs

The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (pcv2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a pcv2 infection. ... Boehringer Ingelheim Vetmedica Gmbh

Porcine epidemic diarrhea virus vaccine

The present invention relates to a vaccine for protecting a pig against diseases associated with porcine epidemic diarrhea virus. The vaccine commonly includes inactivated/killed pedv (e.g., chemically inactivated ped virus), and/or recombinant pedv antigen and an adjuvant. ... Boehringer Ingelheim Vetmedica Gmbh

Connecting and container system

A connecting system for providing a fluidic connection, preferably between containers, wherein the connecting system has at least two connecting arrangements configured to produce the fluidic connection, the connecting arrangements each having an opening region which is fluidically sealed in an initial state and is, in particular, film-shaped, brittle, fragile and/or unstable, and wherein the opening regions are each covered in sterile or sterilizable manner.. . ... Boehringer Ingelheim Vetmedica Gmbh

Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats

A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin ii receptor 1 (at-1) antagonist (sartan).. ... Boehringer Ingelheim Vetmedica Gmbh

Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart disease

A phosphodiesterase type iii (pde iii) inhibitor or ca2+-sensitizing agent or a pharmaceutically acceptable derivative thereof is provided for the preparation of a medication for the reduction of the heart size of a patient suffering from heart failure.. . ... Boehringer Ingelheim Vetmedica Gmbh

Meloxicam for the treatment of respiratory diseases in pigs

A method of treating or preventing a respiratory disease in a pig is described that includes administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically acceptable salt thereof.. . ... Boehringer Ingelheim Vetmedica Gmbh

Modular antigen transportation molecules and uses therof

The present invention relates to (isolated) recombinant proteins, also referred to as improved mat (imat) molecules, comprising at least one translocation module, at least one targeting module and at least one antigen module, wherein at least one cysteine residue is substituted with a different amino acid residue. Such imat molecules are useful specifically as vaccines, e.g., for therapy and/or prevention of allergies and/or infectious diseases and/or prevention of transmission of infectious diseases in equines. ... Boehringer Ingelheim Vetmedica Gmbh

Light member on a package to provide information to a user

Packages that include at least one medicament therein include at least one light member affixed thereto that is capable of emitting light upon activation. The light member is activated upon the opening of the package such that, upon opening, the light member fluoresces or otherwise emits light to provide information to an end user. ... Boehringer Ingelheim Vetmedica Gmbh

Pcv2 immunogenic compositions and methods of producing such compositions

An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. The method generally involves the steps of transfecting recombinant virus containing open reading frame 2 coding sequences into cells contained in growth media, causing the virus to express open reading frame 2, and recovering the expressed protein in the supernate. ... Boehringer Ingelheim Vetmedica Gmbh

Multivalent pcv2 immunogenic compositions and methods of producing such compositions

An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. Also provided is recombinant pcv2 orf2 protein, and immunogenic compositions comprising pcv2 orf2 protein. ... Boehringer Ingelheim Vetmedica Gmbh

Container system and method

A container system having at least two containers, wherein the container system comprises a light member which is configured to provide information through the emission of light, wherein the container system is configured to provide or trigger the light member to provide the information through the emission of light when a step related to preparing a mixture of contents of the containers is performed. In particular, triggering occurs when the containers are separated from one another and/or when a fluidic connection is created between the containers.. ... Boehringer Ingelheim Vetmedica Gmbh

Inhaler

An inhaler with a respiration indicator, whereby the inhaler has a chamber wall forming a chamber and a dispensing device for fluidic connection of the chamber to a bodily opening, preferably a nostril, whereby the respiration indicator has a wall section of the chamber wall or is formed in this way, whereby the wall section is designed to indicate a respiratory activity by deformation and/or movement.. . ... Boehringer Ingelheim Vetmedica Gmbh

Ciclesonide for the treatment of airway disease in horses

Methods of treating airway diseases in equines include administering to an equine an effective amount of ciclesonide or a pharmaceutically acceptable salt thereof or a composition including ciclesonide or a pharmaceutically acceptable salt thereof.. . ... Boehringer Ingelheim Vetmedica Gmbh

06/07/18 / #20180153523

Method for obtaining a saliva sample and collecting device

A method for obtaining a saliva sample from an animal, particularly a pig, by means of a receiving device and a collecting device with an integrated filter, and a method of using a collecting device with an integrated filter for obtaining a saliva sample from an animal, particularly a pig. In addition, a collecting device comprising a bag, a removable container and a filter, and a kit having such a collecting device, and a receiving device for taking saliva from an animal, particularly a pig.. ... Boehringer Ingelheim Vetmedica Gmbh

05/31/18 / #20180147278

Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof

The present invention relates to a porcine parvovirus and porcine reproductive and respiratory syndrome virus vaccine for protecting a subject, preferably swine, against diseases associated with porcine parvovirus and porcine reproductive and respiratory syndrome virus. The present invention further relates to methods of producing immunogenic compositions as well as such immunogenic compositions exhibiting reduced virucidal activity.. ... Boehringer Ingelheim Vetmedica Gmbh

05/17/18 / #20180133309

Vaccine against porcine parvovirus

The present invention relates to a porcine parvovirus (ppv) viral protein 2 (vp2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said ppv viral protein 2 (vp2). ... Boehringer Ingelheim Vetmedica Gmbh

05/10/18 / #20180125957

Immunogenic composition comprising mycoplasma antigens

The present invention relates to an immunogenic composition comprising: a) one or more antigen of m. Hyorhinis and one or more antigens of m. ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180101706

Cartridge and analysis system for testing a sample

A cartridge, an analysis system, a method and a computer program product for testing a sample, such as, environmental, food or biological sample, wherein the cartridge has two memory means that are different and/or can be read out by different methods and which correspond to the cartridge or to the batch thereof.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180100870

Method system for testing a sample

An analysis system and a method for testing a biological sample are proposed, wherein certain pieces of at least two different pieces of control information are selected and/or used to carry out the test using a cartridge and/or certain pieces of at least two different pieces of evaluation information are selected and/or used to evaluate the measurement results determined by the test.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180100869

Analysis system for testing a sample

An analysis system and a method for testing a biological sample is proposed, wherein an operating instrument is provided which preferably can be separated from an analysis device with respect to a data connection and/or wirelessly connected to the analysis device.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180100188

Analysis system and method for testing a sample

An analysis system and a method for testing a biological sample wherein a plurality of assays selected from at least two assays from a group consisting of a protein assay for detecting a target protein, a nucleic-acid assay for detecting a target nucleic-acid sequence and/or an aptamer assay for detecting another target analyte, the testing is carried out sequentially in a common sensor array by means of a sensor apparatus.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180100187

Method and analysis system for testing a sample

A method and an analysis system for testing a biological sample, nucleic-acid products being hybridized to capture molecules of a sensor apparatus at different temperatures.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099286

Method for controlling an analysis device and analysis system

An analysis system and a method for testing a biological sample is proposed, wherein, before the start of the test, the amount of energy remaining in an energy storage means of the analysis device is compared with an energy requirement for the test, and the test is only started if the amount of energy meets the energy requirement, and/or a temperature-control apparatus designed for temperature-controlling the cartridge is controlled depending on an interior space temperature of the analysis device.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099285

Method and analysis system for testing a sample

An analysis system and a method for testing, in particular, a biological sample, the sample and/or analytes of the sample being temperature-controlled in advance or denatured immediately before the test, and/or being heated, the heat being transferred through a chip of a sensor apparatus.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099281

Analysis device and method for testing a sample

An analysis device and method for testing a biological sample by means of a receivable cartridge are proposed, the analysis device comprising at least one actuator for actuating a valve of the cartridge. The actuator comprises a pneumatically loaded membrane and an actuation element that is coupled to said membrane, the return movement into an unactuated position being performed preferably as a result of restoring forces of the membrane.. ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099280

Cartridge, analysis system and method for testing a sample

A cartridge, an analysis system and a method for analysing an in particular biological sample is proposed, wherein a first group having one or more valves and a second group having one or more valves can be or are actuated from different sides of the cartridge.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099279

Analysis device and method for testing a sample

An analysis device and a method for testing a biological sample are proposed, a cartridge being received in the analysis device and valves of the cartridge being opened automatically.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099278

Analysis system for testing a sample

An analysis system for testing a biological sample wherein a sensor cover can be or is pneumatically lowered onto a sensor apparatus in order to detect an analyte of the sample.. . ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099277

Cartridge for testing a sample

A cartridge for testing a biological sample. The cartridge has a closure element that is fastened to the cartridge in a form-fit or interlocking manner and is a multi-component injection molded closure part having an integrated seal so as to be able to fluidically close a receiving cavity having an integrated vent. ... Boehringer Ingelheim Vetmedica Gmbh

04/12/18 / #20180099276

Analysis system and method for testing a sample

A method for testing a biological sample wherein the sample is divided into a plurality of sample portions, is fed to a sensor arrangement in a first conveying direction and is carried away in a second conveying direction which is opposite to the first conveying direction, and/or a sensor cover is lowered onto a sensor apparatus multiple times. Furthermore, a cartridge for testing a biological sample wherein different fluidic circuits can be formed by actuating valves in the cartridge, and the sample or another fluid can be conveyed in the fluidic circuits by means of a pump apparatus.. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080047

Promoters

The present invention relates to the field of (vector) vaccines, and especially to novel promoter sequences, expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080045

Canine adenovirus vectors

The present invention relates to the field of cadv vector vaccines, and especially to promoters suitable to express target antigens from such vector vaccines. Disclosed and claimed are recombinant canine adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing dna and methods of using the compositions and vector), expression products from them, and uses for the expression products. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080044

New swine influenza vaccine

The present invention relates to equine herpes virus (ehv) vectors comprising at least one exogenous antigen encoding sequence relating to a pathogen infecting food producing animals, wherein said exogenous antigen encoding sequence is inserted into an insertion site, preferably orf70, and said exogenous antigen encoding sequence is operably linked to a promoter sequence, preferably the promoter sequence comprising 4pgg600 (seq id no:1) or 4pmcp600 (seq id no:2) or the complementary nucleotide sequences thereof or a functional fragment or a functional derivative thereof or the complementary nucleotide sequences thereof. Furthermore, the present invention relates to methods for immunizing a food producing animal comprising administering to such food producing animal an immunogenic composition comprising embodiments of the present invention. ... Boehringer Ingelheim Vetmedica Gmbh

03/22/18 / #20180080043

Ehv insertion site orf70

The present invention relates to the field of (vector) vaccines, and especially to the novel ehv insertion site orf70. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. ... Boehringer Ingelheim Vetmedica Gmbh

02/08/18 / #20180036316

Treatment of epileptic disorders in feline animals

A method for treatment and/or prevention of one or more epileptic disorders in a feline animal, preferably a cat, includes administration of 1-(4-chlorophenyl)-4-(4-morpholinyl)-2.5-dihydro-1h-imidazol-2-one or a physiologically acceptable salt thereof to the feline animal.. . ... Boehringer Ingelheim Vetmedica Gmbh








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Boehringer Ingelheim Vetmedica Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boehringer Ingelheim Vetmedica Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###